Lv5
1440 积分 2024-12-17 加入
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
20小时前
待确认
Low Colorectal Tumor Removal by E-Cadherin Destruction-Enabled Tumor Cell Dissociation
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
2个月前
已完结
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
2个月前
已完结
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial
2个月前
已完结
The gut-brain axis in the context of colorectal cancer
4个月前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
5个月前
已完结
[Expert consensus on the diagnosis and treatment of colorectal cancer peritoneal metastasis (2025 edition)]
6个月前
已完结
[Expert consensus on the diagnosis and treatment of colorectal cancer peritoneal metastasis (2025 edition)]
6个月前
已完结
Two decades of progress in gastric cancer peritoneal metastasis: a bibliometric perspective on molecular mechanisms and therapeutic innovations
6个月前
已完结
皖公网安备34019202002308
